Skip to main content
DHR logo

Danaher Corp

Exchange: NYSESector: HealthcareIndustry: Diagnostics & Research

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com. © 2025 Beckman Coulter. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. 2025-14761 SOURCE Beckman Coulter Diagnostics

Did you know?

Price sits at 26% of its 52-week range.

Current Price

$191.12

+0.17%

GoodMoat Value

$93.20

51.2% overvalued
Profile
Valuation (TTM)
Market Cap$135.00B
P/E37.35
EV$148.01B
P/B2.57
Shares Out706.35M
P/Sales5.49
Revenue$24.57B
EV/EBITDA21.38

Danaher Corp (DHR) Dividends

GoodMoat Analysis

Based on data as of March 26, 2026

Danaher's dividend profile is stable but not a primary attraction for an income-focused value investor. The dividend is well-covered by free cash flow and the balance sheet is strong, but the yield is low and growth is modest. Capital is primarily reinvested into the business, which aligns with its historical strategy of high-return acquisitions and internal growth.

Read full analysis
For an income-focused investor, Danaher presents a profile of safety over high yield. The current dividend yield of 0.66% is below the broader healthcare sector average, making it a minor component of total return. The dividend's sustainability, however, is strong. The company generates a free cash flow yield of 4.0%, which comfortably covers the dividend payout. This aligns with the 'Strong' rating for Free Cash Flow generation in the GoodMoat framework, which favours FCF margins above 10-15% and high conversion. The balance sheet is also robust, with a low Debt/Equity ratio of 0.35, supporting a 'Strong' rating on that Quality Indicator as it indicates a substantial net cash position and low financial risk. Dividend growth has been consistent but modest, reflecting management's capital allocation priority towards reinvestment and strategic acquisitions to fuel growth, rather than maximizing shareholder payouts. This strategy is evidenced by the company's historical focus on high ROIC acquisitions and internal R&D. Therefore, while the dividend itself is secure and growing, the company's model is geared towards creating value through business growth and strategic capital deployment, which has historically generated high returns on invested capital.

Dividend Overview

Dividend Yield

0.65%

Dividend / Share

$1.24

Key Metrics

Market Cap

$135.00B

P/E Ratio

37.35

Forward P/E

EPS

$5.05

PEG Ratio

2.95

Book Value

$74.37

Dividend Yield

0.65%

Profit Margin

14.71%

ROE

6.88%

Dividend History

Dividend Safety

DHR Dividend Analysis

Danaher Corp (DHR) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 0.65%. The annual dividend per share is $1.24.

P/E ratio: 37.35. Profit margin: 14.71%. Free cash flow: $5.29B. This page shows Danaher Corp's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.

GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Danaher Corp's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.